Vaccini Esavalente e anti-MPR: confronto delle coperture vaccinali in cinque Regioni italiane dopo l’introduzione dell’obbligo.

Translated title of the contribution: [Autom. eng. transl.] Hexavalent and anti-MPR vaccines: comparison of vaccination coverage in five Italian regions after the introduction of the obligation.

Gianfranco Damiani, Patrizia Laurenti, Nicola Magnavita, Umberto Moscato, Gualtiero Ricciardi, Leonardo Villani, Andrea Gentili, Teresa Eleonora Lanza, Domenico Pascucci

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

[Autom. eng. transl.] Introduction Vaccination is a fundamentally important medical act and represents one of the most effective and safe interventions in public health. The introduction of the vaccination obligation with Law Decree 73/2017 has led to an increase in vaccination coverage (CV) with encouraging but not entirely satisfactory results. The study aims to highlight the data obtained in five Italian Regions taken as a reference (Lombardy, Veneto, Emilia-Romagna, Tuscany, Puglia) about the Hexavalent and anti-MPR vaccine, relating to the whole year 2018 in the cohorts born in 2016 at 24 months. Materials and methods A review was carried out on the intermediate and final data relating to the CVs which made it possible to analyze the trend with particular reference to the Hexavalent and anti-MPR vaccine. The statistical analysis conducted highlighted the differences compared to the 2017 data, considering both the raw data and the adjusted data. Results There are differences in CV values between the Regions and also within the same Region, with an uneven increase. In particular, compared to 2017: • the CVs for Hexavalent and anti-MPR in Lombardy reached 95.2% (+ 0.9%) and 94.1% (+ 0.2%) respectively; • Veneto shows an increase of between 1.3% and 1.8% for vaccinations contained in the Esavalente, however not exceeding 93.7%; anti-MPR reaches 92.7% (+ 1.2%); • the CV for the Esavalente in Emilia-Romagna goes from 94.7% to 95.7% (+ 1%); anti-MPR from 91.1% to 93.5% (+ 2.4%); • the CVs for Hexavalent and anti-MPR in Tuscany go from 95.8% to 96.8% (+ 1%) and from 93.5% to 95.32% (+ 1.8%) respectively; • the CVs for the Esavalente in Puglia went from 94.4% to 95.2% (+ 0.8%); those for anti-MPR from 91.1% to 94.2% (+ 3.1%); in this region there is a greater percentage increase for anti-MPR vaccination. Conclusions Despite the introduction of the vaccination obligation and the consequent increase in CVs, the Tuscany Region is the only one among the five analyzed that reaches the optimal CV values for both vaccinations (> 95%). Even within the Regions analyzed, there are significant differences in the CVs reached in the individual provinces, highlighting how the management of the offer is still uneven. We consider this data linked to various factors that can and must be corrected, such as the delay in confirming the mandatory vaccination, the difficulties of organization and management in the supply of the offer by the vaccination centers, the supply of the necessary tools and the then absence of the operational and complete national vaccination registry.
Translated title of the contribution[Autom. eng. transl.] Hexavalent and anti-MPR vaccines: comparison of vaccination coverage in five Italian regions after the introduction of the obligation.
Original languageItalian
Title of host publicationAtti del 52° Congresso Nazionale SItI – “Le evidenze scientifiche per la Sanità Pubblica: dalle emergenze alla promozione della salute”.
Pages286
Number of pages1
Publication statusPublished - 2019
Event52° Congresso Nazionale SItI – “Le evidenze scientifiche per la Sanità Pubblica: dalle emergenze alla promozione della salute”. - Perugia Hotel Giò Wine e Jazz Area
Duration: 16 Oct 201919 Oct 2019

Conference

Conference52° Congresso Nazionale SItI – “Le evidenze scientifiche per la Sanità Pubblica: dalle emergenze alla promozione della salute”.
CityPerugia Hotel Giò Wine e Jazz Area
Period16/10/1919/10/19

Keywords

  • copertura vaccinale

Fingerprint Dive into the research topics of '[Autom. eng. transl.] Hexavalent and anti-MPR vaccines: comparison of vaccination coverage in five Italian regions after the introduction of the obligation.'. Together they form a unique fingerprint.

Cite this